This study observed the ALK‐rearrangement rate was 9.4%, which is much higher than that reported among Asian patients with NSCLC of 4.1–5%.23 This difference may be related to the clinicopathological characteristics of the included patients. The gene discussed is ALK; the disease is non-small cell lung carcinoma.